DeStefano, Compliance, Transparency, Visibility: A U.S. Perspective: Cloudy At Best
9-22-11 Anti-Bribery and Corruption Prevention
Challenges of Conducting Due Diligence Investigations in China
8 th Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum Preconference III Global Compliance Update Ted Acosta Ernst & Young.
0 Overview of the Foreign Corrupt Practices Act and Related Corporate Procedures (A312, A312A and A301)
Corruption
